Bortezomib improves initial treatment response in multiple myeloma
Results of a European Group (VISTA) shows that adding bortezomib to melphalan and prednisone improves initial response in myeloma patients over 65 who are unsuitable for high-dose therapy....
Want to read complete article? Please Sign in or Register.